Clinical Trials Directory

Trials / Completed

CompletedNCT01644071

Serotonergic System and Violent Video Games

Genetic-pharmacological Neuroimaging of the Serotonergic System in Violent Video Games

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
RWTH Aachen University · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Aggressive behavior (AB) is a major burden to society with severe socio-economic consequences. Genetic studies suggest a high heritability of AB; in particular, the low expressing allele of the MAOA gene (MAOA-L) has been associated with increased AB. Recent neural aggression models have suggested a dysfunctional emotion regulation circuit including amygdala, orbitofrontal, and anterior cingulate cortex. Dysregulated serotonergic (5-HT) projections from the anterior cingulate cortex to the amygdala have been suggested to promote aggressive behavior. This finding is well in line with the observation that the MAOA-L allele leads to a reduced expression of monoamine oxidase A and thus to an overflow of 5-HT in serotonergic cortico-amygdalar projections. However, due to methodological and ethical constraints, the neural substrates of AB are difficult to assess. A possible solution is the use of virtual violence which permits AB against virtual characters without direct consequences for any real person and can be easily applied in functional imaging experiments. There is evidence that virtual and real aggression share common neural substrates. AB in violent video games inhibits rostral anterior cingulate cortex (ACC) and amygdala in line with the suggested neurophysiological circuits underlying real-life AB.

Detailed description

Our study plan comprises the assessment of brain activation patterns during virtual AB in a violent video game with functional magnetic resonance imaging under three experimental conditions in randomized, double-blind fashion: 1. Increase of synaptic 5-HT with a selective serotonin reuptake inhibitor (SSRI, Cipralex ®); 2. reduction of synaptic 5-HT with the Rapid Tryptophan Depletion Test (RTD); and 3) Placebo. A blood sample genotyping will assess the allelic expression of the MAOA gene. We hypothesize 1. a modification of the ACC-amygdala system by the serotonergic intervention and 2. an interaction with the genotype concerning the MAOA gene. The results of this study will give valuable insights into the neurogenetic biology underlying aggression which will open new perspectives for therapeutical and pharmacological intervention.

Conditions

Interventions

TypeNameDescription
DRUGcipralexone time 10 mg, tablet

Timeline

Start date
2012-02-01
Primary completion
2014-02-01
Completion
2014-06-01
First posted
2012-07-18
Last updated
2015-09-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01644071. Inclusion in this directory is not an endorsement.